Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pharmix

2001 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of drug-engineering platform to various pharmaceutical companies. The company develops therapeutic programs that include compounds for treating type II diabetes, cardiovascular disease, cancer, HIV or AIDs and topical inflammation.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Acquirer
Primary Office
  • 2000 Sierra Point Parkway
  • Suite 500
  • Brisbane, CA 94005
  • United States

Pharmix Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Pharmix‘s full profile, request access.

Request full access to PitchBook